Φορτώνει......
Reprofiling of approved drugs against SARS-CoV-2 main protease: an in-silico study
Given the COVID-19 pandemic, currently, there are many drugs in clinical trials against this virus. Among the excellent drug targets of SARS-CoV-2 are its proteases (Nsp3 and Nsp5) that plays vital role in polyprotein processing giving rise to functional nonstructural proteins, essential for viral r...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Biomol Struct Dyn |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Taylor & Francis
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7678354/ https://ncbi.nlm.nih.gov/pubmed/33179586 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/07391102.2020.1845976 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|